Hospitals, CROs, research labs, and tech transfer offices: join the IGVP OS to run trials for venture-backed startups and commercialize lab IP globally.
Cross-Border Desk · Live Sourcing
AIIMS Cardiology Trial Wing
Matched with 3 Delaware C-Corp medtech ventures
C-CAMP Licensing Desk
2 provisional patents under licensing review
Co-Development Deal Pipeline
First-look access to top Accelerator ventures
Monetize research infrastructure, clinical trial capacity, and university tech transfer IP
Your institution has trial capacity, research infrastructure, or licensable IP sitting underutilized — but no structured channel to reach credible, investment-ready ventures on the other side of the border.
Common Obstacles & Bottlenecks:
Hospital trial wings operating under 50% capacity due to high Western sponsor costs.
High-potential academic IP gathering dust without commercialization channels.
Bureaucratic delay in executing CDSCO/FDA multi-center research agreements.
IGVP integrates your institution directly into our Accelerator deal flow — filling trial capacity with pre-funded ventures and licensing institutional IP under standard 80/20 commercial terms.
IGVP System Advantages:
Direct assignment of Delaware C-Corp ventures with pre-allocated trial budgets.
Standardized 80/20 IP licensing frameworks for university research labs.
Fast-track legal and ethical board clearance with IGVP template agreements.
Program Deliverables
Direct placement of venture-backed startups into your clinical trial wards and patient registries.
Listing lab patents in front of IGVP Accelerator founders and LP syndicates seeking commercial IP.
Standardized CDSCO & FDA IRB/Ethics board clearance templates to slash onboarding delays.
First-look access to joint research & grant funding programs sponsored by IGVP Bio Fund.
Self-segment upon entry into verified channels designed to accelerate co-founder matching, clinical trials, due diligence, and capital deployment.
Institutional Accreditation Check
Verified for verified CROs, hospital leads & Tech Transfer officers
Category Channels
Cross-Pollination Engine: Members collide across co-founder matching and deal-flow channels to fuel the Tri-Engine Flywheel.
We have opened 20 cardiology trial slots for Q3 at the New Delhi campus. Looking for pre-funded Delaware C-Corp medtech ventures.
Dr. Roy! We just closed our $1.5M seed round and have our FDA pre-sub approved. Sending our trial protocol to your desk now.
See how academic medical centers, health systems, and tech transfer offices commercialize breakthrough research through IGVP.
"IGVP's institutional desk streamlined our tech-transfer licensing process. 3 of our university patents spun out into funded startups this year."
Dr. Arthur Pendelton
VP Research · Stanford Health Innovation
3 PATENTS LICENSED
"Our health system onboarded 4 clinical trial cohorts through IGVP's pre-diligenced founder channel with IRB approvals completed in under 30 days."
Dr. Jonathan Roy
Director of Clinical Trials · Mass General
4 CLINICAL TRIALS
"The cross-border IRB and CDSCO/FDA clearance desk allowed our academic spinout to launch dual trials in Boston and Hyderabad simultaneously."
Prof. Sunita Reddy
Head of Bio-Design · IIT BioLab
DUAL IRB CLEARANCE
"IGVP provides our faculty founders with direct capital market access and venture partner mentorship, increasing spinout survival rates."
Clara Vance
Tech Transfer Officer · Johns Hopkins TTO
92% SPINOUT SURVIVAL
"IGVP's institutional desk streamlined our tech-transfer licensing process. 3 of our university patents spun out into funded startups this year."
Dr. Arthur Pendelton
VP Research · Stanford Health Innovation
3 PATENTS LICENSED
"Our health system onboarded 4 clinical trial cohorts through IGVP's pre-diligenced founder channel with IRB approvals completed in under 30 days."
Dr. Jonathan Roy
Director of Clinical Trials · Mass General
4 CLINICAL TRIALS
"The cross-border IRB and CDSCO/FDA clearance desk allowed our academic spinout to launch dual trials in Boston and Hyderabad simultaneously."
Prof. Sunita Reddy
Head of Bio-Design · IIT BioLab
DUAL IRB CLEARANCE
"IGVP provides our faculty founders with direct capital market access and venture partner mentorship, increasing spinout survival rates."
Clara Vance
Tech Transfer Officer · Johns Hopkins TTO
92% SPINOUT SURVIVAL